PlainRecalls
FDA Drug Critical Class I Terminated

Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05

Reported: August 26, 2020 Initiated: July 21, 2020 #D-1505-2020

Product Description

Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05

Reason for Recall

Superpotent Drug

Details

Units Affected
184,325 nasal sprays
Distribution
Nationwide within the United States.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05. Recalled by Ferring Pharmaceuticals Inc. Units affected: 184,325 nasal sprays.
Why was this product recalled?
Superpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2020. Severity: Critical. Recall number: D-1505-2020.